Bavarian Nordic to Present at Jefferies 2015 Global Healthcare Conference in New York
(Thomson Reuters ONE) -
KVISTGAARD, Denmark - May 28, 2015 - Bavarian Nordic A/S (OMX: BAVA, OTC:
BVNRY) announced today that Paul Chaplin, President & Chief Executive Officer
will provide a corporate presentation at the Jefferies 2015 Global Healthcare
Conference in New York on Monday, June 1, 2015 at 4:00 p.m ET.
A live and archived webcast of the presentation can be accessed through the
Company's website www.bavarian-nordic.com under "Investor & Media > Events".
About Bavarian Nordic
Bavarian Nordic is a biopharmaceutical company focused on the development and
manufacturing of cancer immunotherapies and vaccines for infectious diseases.
Through a long-standing collaboration with the U.S. Government, Bavarian Nordic
has developed a portfolio of biological countermeasures, including the non-
replicating smallpox vaccine, IMVAMUNE®, which is stockpiled for emergency use
by the U.S. and other governments. The vaccine is approved in the EU (under the
trade name IMVANEX®) and in Canada. Bavarian Nordic and its partner Janssen are
pioneering the development of an Ebola vaccine, which has been fast-tracked by
authorities in response to the current situation in West Africa. Additionally,
in collaboration with the National Cancer Institute, Bavarian Nordic has
developed a portfolio of active cancer immunotherapies based on its versatile
pox-virus based technologies, including PROSTVAC®, which is currently in Phase
3 clinical development for the treatment of advanced prostate cancer. The
company has partnered with Bristol-Myers Squibb for the potential
commercialization of PROSTVAC. For more information visit www.bavarian-
nordic.com or follow us on Twitter (at)bavariannordic.
Contacts
U.S.: Seth Lewis, Vice President, Investor Relations. Phone: + 1 978 341 5271
Europe: Rolf Sass Sørensen, Vice President Investor Relations & Communications.
Phone +45 61 77 47 43
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Bavarian Nordic A/S via GlobeNewswire
[HUG#1924602]
Unternehmensinformation / Kurzprofil:
Datum: 28.05.2015 - 18:00 Uhr
Sprache: Deutsch
News-ID 396585
Anzahl Zeichen: 2597
contact information:
Town:
Kvistgård
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 143 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Bavarian Nordic to Present at Jefferies 2015 Global Healthcare Conference in New York"
steht unter der journalistisch-redaktionellen Verantwortung von
Bavarian Nordic A/S (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
